Method for preparing a medical material for replacing a hard tissue defect and a medical material prepared therefrom
The present invention relates to a method for preparing a medical material for replacing a hard tissue defect and a medical material produced therefrom. More specifically, in the present invention, powders of bioactive glass are press-molded, and are then subjected to a first heat treatment at a relatively low temperature below the glass transition temperature of bioactive glass. Then, the resultant is processed into a desired shape and then subjected to a second heat treatment at a temperature higher than the glass transition temperature of bioactive glass. Accordingly, the present invention provides a medical material which can be customized to a desired shape of a hard tissue defect in a living body and minimize thermal shock, and which is capable of exhibiting a bone fusion property, while overcoming the low compressive strength drawback of hydroxyapatite, which is an existing hard tissue replacement material currently in use.
1. A method for preparing a medical material for replacing a hard tissue defect in a living body, comprising:
a first step of preparing a molded product by press-molding powders of bioactive glass;
a second step of subjecting the molded product to a first heat treatment at 650° C. to 745° C.;
a third step of designing a product shape based on a predetermined contraction rate during a second heat treatment, the product shape having the shape of a hard tissue defect within an error range of 0-5% based on a length in a single-axis direction of the shape of the hard tissue defect, and machining the first heat-treated product to form the designed product shape; and
a fourth step of subjecting the machined product to a second heat treatment at 850° C. to 1,200° C.
wherein the bioactive glass comprises CaO, SiO 2 , Na 2 O, and P 2 O 5 .
2. The method according to claim 1 , further comprising a fifth step of performing a slow cooling of the machined product subjected to the second heat treatment after the fourth step.
3. The method according to claim 1 , wherein the bioactive glass further comprises at least one selected from MgO, B 2 O 3 , and CaF 2 .
4. The method according to claim 1 , wherein the powders of the bioactive glass are further mixed with a dispersant, followed by press-molding.
5. The method according to claim 4 , wherein the dispersant is polyvinyl alcohol (PVA), polyvinyl butyral (PVB), poly(methyl methacrylate) (PMMA), polyethylene glycol (PEG), methylcellulose, hydroxy methylcellulose, sodium carboxymethyl cellulose, paraffin, wax emulsion, microcrystalline wax, ethanol, or a mixture thereof.
6. The method according to claim 1 , wherein the press-molding in the first step is cold isostatic pressing (CIP).
7. The method according to claim 1 , wherein the contraction during the second heat treatment is isostatic contraction.
8. The method according to claim 1 , wherein the contraction rate during the second heat treatment is 15% to 25% based on the length in a single-axis direction.
9. The method according to claim 2 , wherein the slow cooling in the fifth step is performed at a rate of less than 5° C./min.
10. The method according to claim 1 , wherein the product shape in the third step is designed following the procedure shown below:
obtaining a medical image of the living body,
modeling the hard tissue defect based on the medical image, and
re-modeling the modeled hard tissue defect by applying the predetermined contraction rate during the second heat treatment, thereby obtaining the product shape.